Nevirapine Wockhardt Uk

Nevirapine, the active ingredient in Nevirapine Wockhardt Uk, is a Non-nucleoside reverse transcriptase inhibitor (NNRTI) presented as an oral tablet for oral use. It is employed in the treatment of HIV-1 infection in adults and children. The drug works by binding to the HIV-1 reverse transcriptase enzyme, causing a conformational change that blocks the polymerase activity required for viral replication.

GNH USA supplies Nevirapine Wockhardt Uk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple jurisdictions.

Nevirapine is an NNRTI used in antiretroviral regimens targeting HIV-1 replication.

- HIV-1 infection (adults): reduces viral load and improves CD4+ T-cell counts. - HIV-1 infection (children): achieves viral suppression in pediatric patients when combined with other antiretrovirals. - Treatment-naïve patients: provides an effective option as part of first-line therapy. - Combination antiretroviral therapy: contributes to multi-drug regimens to prevent resistance development.

Nevirapine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Rash - Nausea - Fatigue - Headache - Dizziness - Abdominal pain

Serious or Rare Side Effects: - Stevens-Johnson syndrome - Hepatic failure - Severe skin reactions - Hypersensitivity syndrome - Neutropenia - Anaphylaxis

When prescribing Nevirapine, clinicians should observe several safety considerations to minimize risks.

- Liver function monitoring: perform baseline and periodic liver enzyme tests. - Skin reactions: discontinue immediately if severe rash or mucosal involvement occurs. - Monotherapy avoidance: use only as part of combination antiretroviral therapy to reduce resistance. - Pregnancy and breastfeeding: evaluate risk-benefit; use only if benefits outweigh potential fetal or infant risks. - Drug interaction review: assess concomitant medications for potential interactions. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nevirapine interacts with several agents that can alter its plasma concentrations or increase toxicity.

Major Interactions (Avoid): - Ritonavir-boosted protease inhibitors: may raise nevirapine levels leading to hepatotoxicity. - St. John’s wort (Hypericum perforatum): can markedly reduce nevirapine exposure, compromising efficacy.

Moderate Interactions (Monitor Closely): - Efavirenz: additive central nervous system effects may require monitoring. - Fluconazole: may increase nevirapine concentrations, necessitating liver function surveillance. - Methadone: nevirapine can lower methadone levels, potentially precipitating withdrawal.